RVTY
HOLD / NEUTRALMeanRevComposite
51.70
Technical
81.50
Fundamental
41.70
Rank
—
Price
111.39
Hurst
0.32
As of
Aug 5, 2026
Daily
Revvity, Inc.
HealthcareDiagnostics & ResearchRevvity provides diagnostic instruments, reagents, software, and related services across healthcare and life sciences. The company's products support disease detection and screening—including prenatal testing, infectious disease diagnostics, genetic disorder identification, and oncology applications—serving pharmaceutical firms, laboratories, hospitals, and government health agencies. The organization also develops genomic and immunodiagnostic technologies used in drug discovery and research workflows.
Market cap
$16.4B
P/E (trailing)
69.87
P/E (forward)
24.90
PEG ratio
0.73
Dividend yield
19.00%
Beta
1.09
52w range
81.22 – 149.52
Return on equity
+3.21%
Profit margin
+8.16%
Revenue growth
+1.30%
Earnings growth
+1.20%
Price history
1Y: 146.73 (+67.7%) · range 82.21–146.73
Cycle position
75/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 4 · NOT READY · exit proximity 30
Conviction
27/ 100 · maturity 100%
VScore.4017
Buildup.2064
EMA entry setup.254
Fundamentals.1542
Volume profile
POC
111.93
Price vs POC
+31.1%
Overhead supply
1%
Runway
open sky
Value area 86.64–118.08 · 1% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.212 | Sep 17, 2026 |
| earnings-surprise | 0.033 | Sep 2, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +13.84% | +13.84% | mature |
| 40d | +8.08% | +13.84% | 26/40d |